Compare TTK HEALTHCARE with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE CADILA HEALTHCARE TTK HEALTHCARE/
CADILA HEALTHCARE
 
P/E (TTM) x 20.1 30.2 66.4% View Chart
P/BV x 1.3 3.6 37.3% View Chart
Dividend Yield % 1.1 1.0 120.2%  

Financials

 TTK HEALTHCARE   CADILA HEALTHCARE
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
CADILA HEALTHCARE
Mar-19
TTK HEALTHCARE/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,215432 281.0%   
Low Rs610306 199.1%   
Sales per share (Unadj.) Rs444.4128.6 345.5%  
Earnings per share (Unadj.) Rs17.218.5 93.0%  
Cash flow per share (Unadj.) Rs27.624.4 113.3%  
Dividends per share (Unadj.) Rs5.003.50 142.9%  
Dividend yield (eoy) %0.50.9 57.8%  
Book value per share (Unadj.) Rs177.9101.5 175.4%  
Shares outstanding (eoy) m14.131,023.74 1.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.12.9 71.5%   
Avg P/E ratio x52.919.9 265.7%  
P/CF ratio (eoy) x33.015.1 218.1%  
Price / Book Value ratio x5.13.6 140.8%  
Dividend payout %29.018.9 153.6%   
Avg Mkt Cap Rs m12,894378,170 3.4%   
No. of employees `0002.312.4 18.6%   
Total wages/salary Rs m1,30721,241 6.2%   
Avg. sales/employee Rs Th2,715.710,585.0 25.7%   
Avg. wages/employee Rs Th565.31,707.8 33.1%   
Avg. net profit/employee Rs Th105.41,526.5 6.9%   
INCOME DATA
Net Sales Rs m6,279131,656 4.8%  
Other income Rs m782,011 3.9%   
Total revenues Rs m6,356133,667 4.8%   
Gross profit Rs m49629,731 1.7%  
Depreciation Rs m1475,986 2.5%   
Interest Rs m341,935 1.7%   
Profit before tax Rs m39323,821 1.6%   
Minority Interest Rs m0469 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1495,303 2.8%   
Profit after tax Rs m24418,987 1.3%  
Gross profit margin %7.922.6 35.0%  
Effective tax rate %37.922.3 170.4%   
Net profit margin %3.914.4 26.9%  
BALANCE SHEET DATA
Current assets Rs m2,71784,981 3.2%   
Current liabilities Rs m1,57173,425 2.1%   
Net working cap to sales %18.38.8 208.0%  
Current ratio x1.71.2 149.5%  
Inventory Days Days3275 43.1%  
Debtors Days Days47110 42.6%  
Net fixed assets Rs m991133,493 0.7%   
Share capital Rs m1411,024 13.8%   
"Free" reserves Rs m2,373102,839 2.3%   
Net worth Rs m2,514103,863 2.4%   
Long term debt Rs m339,497 0.0%   
Total assets Rs m4,158234,831 1.8%  
Interest coverage x12.613.3 94.8%   
Debt to equity ratio x00.4 0.4%  
Sales to assets ratio x1.50.6 269.3%   
Return on assets %6.78.9 74.9%  
Return on equity %9.718.3 53.0%  
Return on capital %16.918.3 92.6%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22548,404 0.5%   
Fx outflow Rs m7111,593 0.6%   
Net fx Rs m15436,811 0.4%   
CASH FLOW
From Operations Rs m17328,823 0.6%  
From Investments Rs m97-57,387 -0.2%  
From Financial Activity Rs m-30718,846 -1.6%  
Net Cashflow Rs m-38-7,105 0.5%  

Share Holding

Indian Promoters % 65.4 74.8 87.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 8.3 44.6%  
FIIs % 5.2 5.9 88.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 11.0 234.5%  
Shareholders   12,723 44,069 28.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   SUVEN LIFESCIENCES  SHASUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SUN PHARMA  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 178 Points Higher; Telecom and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest throughout the day today and ended on a positive note.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound(Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jul 3, 2020 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - GLENMARK PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS